Caption Management, LLC Editas Medicine, Inc. Put Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	SELL	$7.03 - $11.53 $5,624 - $9,224	-800 Reduced 1.14%	69,200 $501,000
Q2 2022 Aug 15, 2022	BUY	$9.99 - $21.35 $699,300 - $1.49 Million	70,000 New	70,000 $828,000
Q4 2021 Feb 11, 2022	SELL	$26.55 - $40.57 $4.23 Million - $6.47 Million	-159,500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$39.27 - $72.94 $3.28 Million - $6.09 Million	83,500 Added 109.87%	159,500 $6.55 Million
Q2 2021 Aug 16, 2021	SELL	$31.29 - $56.64 $431,802 - $781,632	-13,800 Reduced 15.37%	76,000 $4.3 Million
Q1 2021 May 17, 2021	BUY	$39.71 - $90.58 $3.57 Million - $8.13 Million	89,800 New	89,800 $3.77 Million

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $154M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.